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Objective: Knee osteoarthritis (OA) is among the higher contributors to global disability. Despite its high
prevalence, currently, there is no cure for this disease. Furthermore, the available diagnostic approaches
have large precision errors and low sensitivity. Therefore, there is a need for new biomarkers to correctly
identify early knee OA.
Method: We have created an analytics pipeline based on machine learning to identify small models
(having few variables) that predict the 30-months incidence of knee OA (using multiple clinical and
structural OA outcome measures) in overweight middle-aged women without knee OA at baseline. The
data included clinical variables, food and pain questionnaires, biochemical markers (BM) and imaging-
based information.
Results: All the models showed high performance (AUC > 0.7) while using only a few variables. We
identiﬁed both the importance of each variable within the models as well its direction. Finally, we
compared the performance of two models with the state-of-the-art approaches available in the
literature.
Conclusions: We showed the potential of applying machine learning to generate predictive models for
the knee OA incidence. Imaging-based information were found particularly important in the proposed
models. Furthermore, our analysis conﬁrmed the relevance of known BM for knee OA. Overall, we
propose ﬁve highly predictive small models that can be possibly adopted for an early prediction of knee
OA.
© 2017 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Nowadays, knee osteoarthritis (OA) is mainly diagnosed using
clinical and radiographic changes generated by structural damages
that occur late in the disease progression. In general, these tech-
niques have a relatively large precision error and low sensitivity1.to: J. Bacardit, School of
ersity, 1 Science Square, Sci-
J. Bacardit).
ternational. Published by Elsevier LGiven the limitations of these imaging-based biomarkers (also
known as “dry”), there is an increased need for identifying new and
sensitive biochemical biomarkers (also called “wet”), other dry
biomarkers (such as coming from MRI), or a combination of both
that can detect early OA before structural damages and established
clinical OA develop. Recently, several new approaches have been
presented to tackle the lack of early knee OA detection2. The levels
of serum COMP have been correlatedwith the development of knee
OA3, the incidence of clinical knee OA among middle-aged over-
weight and obesewomen has been linkedwith the baseline ﬁbulin-
3 concentrations4 and it was shown to be negatively associated
with the baseline concentration of COLL2-1NO25. Finally,td. All rights reserved.
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onset post-traumatic knee OA6.
Machine learning has already been used to elucidate the un-
derlying biological processes related to OA7e9. In the present
study, we use a pipeline (a set of machine learning-based
computational procedures) to analyse a cohort of women at
high-risk for knee OA development with the aim of identifying
novel biomarkers that can contribute to the early detection of
knee OA. The core of this pipeline is represented by Ranked
Guided Iterative Feature Elimination (RGIFE)10, a machine
learning based heuristic designed to generate small yet highly
predictive models from complex biomedical data. Different than
many presented works, we used ﬁve distinct outcome measures
of incident knee OA to generate small predictive models (at most
eight variables) that provide high classiﬁcation performance.
Furthermore, we investigate the contribution and the direction of
each variable within the predictive models. Finally, we contrast
the performance of the proposed models with state-of-the-art
approaches available in the specialised literature. Our method
results effective in identifying relevant factors that are related
with knee OA incidence. More importantly, although focused on
the analysis of data associated with knee OA, the proposed
methodology is generic enough to be applied to a wide variety of
biomedical data. It possesses the potential to discover and analyse
the role of novel biomarkers for many different conditions and
can help in understand their mechanisms.
Method
Dataset and individuals
The data used in this work came from the PROOF study; a pre-
ventive randomised controlled trial including 407 middle-aged
women with a BMI 27 kg/m2 free of clinical knee OA at base-
line11. After 30 months, the preventive effects of a diet & exercise
program and of oral glucosamine sulphate were evaluated. Since no
intervention effects were found, data were here treated as a cohort,
with ﬁve different outcome measures of incident knee OA after 30
months:
C incidence of ‘combined radiographic and clinical ACR-
criteria’
C incidence of frequent knee pain
C lateral JSN of 1.0 mm
C medial JSN of 1.0 mm
C incidence of KL  2
Each individual was characterised by the value of 186 hetero-
geneous baseline variables (the full list of variables is available in
the Supplementary Material). Data were derived from baseline
questionnaires (including demographics, menopausal status, knee
complaints, physical activity level, quality of life, habitual nutri-
tional intake, and KOOS questionnaire), radiographs (for obtaining
baseline KL grade, medial alignment angle, and knee joint shape
using active shape modelling), MR images (scored with semi-
quantitative MOAKS system12 and used to deﬁne MRI OA13),
physical examination (including pain upon palpation of knee
structures, crepitus, presence of Heberden's nodes, blood pressure,
knee laxity and range of motion, warmth of the knee joint, waist
circumference, and skinfolds for fat percentage calculation), and
biochemical markers (BM) from serum and urine (ﬁbulin3-1,
ﬁbulin3-2 and ﬁbulin3-34, COLL2-1NO25, and C1M and C2M14. A
detailed description of the acquisition of non-biochemical variables
is given elsewhere11. Separate analysis was performed for the
different deﬁnition of knee OA. From now onward we will refer tothe ﬁve deﬁnitions, and the associated analysis, as: ACR criteria,
knee pain, lateral JSN, medial JSN and KL incidence.
A machine learning pipeline for the generation of small predictive
models
The RGIFE heuristic
The aim of this study was to identify biomarkers that can
discriminate between incidence and non-incidence for ﬁve different
outcomes measures of knee OA. RGIFE is a machine learning heu-
ristic able to select few biomarkers with high predictive power10.
RGIFE, using an iterative process, discards features if their removal
does not decrease the overall predictive performance of the
computational model. By sequentially repeating the reduction
process and performing other optimisation decisions, the method
has been proven to select small sets of variables with high pre-
dictive power when analysing complex transcriptomics dataset10.
RGIFE has been designed to deal with challenging and difﬁcult
biomedical data, often characterised by a small number of samples
that are likely to be deﬁned in a high-dimensional space (that is
described by thousands of variables). With speciﬁc optimisation
techniques (e.g., oversampling, cost-sensitive learning, etc.), RGIFE
can converge to reduced panels of biomarkers.
In our analysis, RGIFE used the random forest algorithm15 to
build the predictive models. A random forest consists of a collection
of simple decision trees, where each of them is generated using a
random (different) subsets of training samples and variables. The
prediction for each individual is made with a majority vote of the
set of trees. That is, each sample is assigned to the class predicted by
the majority of the decision trees. The PROOF data represented a
difﬁcult task from a machine learning point of view due to: 1)
presence of many missing values and 2) imbalance distribution of
the samples (much more non-incidence than incidence). The
missing values were imputed using the K-means algorithm, while
the imbalanced class distribution problem was tackled using the
SPIDER oversampling method16. For both methods we used the
implementation available in the KEEL machine learning package17.
Identiﬁcation of the best model
RGIFE is a ﬂexible and ﬁne tuneable algorithm, we used 30
different conﬁgurations to perform a full search in the space of all
the optimal solutions (set of biomarkers) for each OA deﬁnition. The
conﬁgurations differed in terms of maximum depth of the random
forest and misclassiﬁcation costs (penalisationwhenmisclassifying
incidence samples during the learning phase).
The best performing conﬁguration was selected with a 10-fold
cross-validation, a typical approach used in machine learning to
evaluate the performance of a predictive model. A n-fold cross-
validation (in our analysis n ¼ 10) randomly divides the dataset
into n equally-sized disjoint subsets (folds), each of them having
the same distribution of positive and negative samples as in the
complete dataset. In turn, each set is used as test set while the
remaining n1 are used as training set. By calculating the perfor-
mance obtained using the test sets we can assess how the model
will generalise to an independent dataset. In our analysis the 10-
fold cross-validation was repeated 10 times to minimise the bias
introduced by the data being split into training and test set. Af-
terwards, using RGIFE on the complete dataset, we identiﬁed the
best performing models (highest AUC calculated with a new
10 10-fold cross-validation) with at most 10 variables. The overall
analytical process is presented in Fig. 1. Because of this pipeline, in
the Results section, wewill report two different AUC values, namely
AUC-CV and AUC-Full. AUC-CV refers to the AUC obtained by the best
performing conﬁguration using a 10  10-fold cross-validation.
AUC-Full, indicates the performance, calculated using a new
Fig. 1. Analytic pipeline employed for the identiﬁcation of the best predictive models. First, using a 10  10-fold cross-validation, the best performing conﬁguration of RGIFE is
identiﬁed. The predictive performance of the best conﬁguration is indicated as AUC-CV. Then, using the selected set of parameters, RGIFE is applied 10 times (to exploit its stochastic
behaviour) to the whole set of samples. Finally, the 10 generated models are ranked using the median AUC obtained with a new 10  10-fold cross-validation. The top ranked model,
whose performance is indicated as AUC-Full, is selected for the biomarker identiﬁcation.
Table I
Baseline characteristics of the included subjects (N ¼ 365)
Mean ± SD or percentage
Age (yr) 55.7 ± 3.2
BMI (kg/m^2) 32.3 ± 4.3
Menopausal status 69%
Western etnicity 96%
Mild symptoms 45%
Physical activity
(SQUASH score)
6900 ± 3700
K&L ¼ 1 60%
K&L ¼ 2 10%
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when considering to the complete set of samples (with RGIFE using
the best performing conﬁguration).
Finally, we used a permutation test to assess if our models
perform better than random ones. We contrasted the performance
of 100 random models, generated from 100 permutated datasets
(where the labels incidence and non-incidence were randomly
assigned) to the AUC obtained from the original data. An empirical
p-value was estimated by counting the number of times in which a
model provides better performance when trained with random
data rather than the original data.
Model interpretation
We analysed the role of the variables, within the models, by
assessing both their (additive) value and their association with the
outcome (incidence of knee OA in this instance). The additive value
was obtained from the generation of sub-models of decremental
sizes, named decremental analysis. That is, from the original set of
variables, we iteratively identiﬁed the one whose removal caused
the smallest drop of AUC, hence contributing the less to the pre-
diction task. The variable direction indicates how the value
assumed by a variable inﬂuences the presence of the disease
(condition). This was accomplished by performing a partial
dependence analysis, a method to visualise the partial relationship
between the outcome and the predictive variables18. The method
evaluates the variations in predictions when the values of the
variables are changed, thus it determines the relationship of the
biomarkers with the outcome measure (see Section 2 of the
Supplementary Material for a more detailed description).
Results
Out of all the subjects included in the PROOF study, 365 had
follow-up data and were selected for the present analysis. The
baseline characteristics of the individuals are presented in Table I. Adifferent total number of subjects was available for different knee
OA outcomemeasures. The ACR criteria and chronic knee pain after
30 months occurred in 39 out 354 (11%) and in 51 out of 351 (15%)
women respectively. The incidence of lateral JSN 1.0 mm was
assessed in 41 (12%) out of 352 women, while medial JSN was seen
in 38 (11%) women out of 352. Finally, the incidence of KL  2 was
measured in 27 (8%) out of 321 individuals. A supplementary
analysis was performed by using an outcome measure that com-
bines four of the outcome measures: ACR criteria, KL score, lateral
and medial JSN. The aimwas to check if a combined measure could
help in generating better models. The results of this analysis are
available in Section 3 of the Supplementary Material.
Best predictive models
In Table II, we report themodels generated from the different OA
deﬁnitions. The variables are grouped based on their source of in-
formation: OA information (OA), clinical information (CI), imaging-
based data (IM), BM, pain (PQ) and food questionnaire (FQ), all
coming from the baseline assessments. Fig. 2 shows the ROC curves
generated from each of the generated models.
The best performing model was generated using the KL inci-
dence OA outcome measure; it obtained an AUC-Full of 0.823 by
Table II
Summary of the best models for each knee OA outcome measure
OA measure Biomarkers Cat. AUC-Full/AUC-CV
ACR criteria C KL grade  1 in one or both knees OA 0.788/0.692
Conf.Int.
0.712-0.863
C Maximal isometric quadriceps strength CI
C Mode 10, Mode 15, Mode 11 (Active Shape Modelling) IM
C Presence of knee pain in the last month, Difﬁculties when kneeling PQ
C C2M concentration BM
Knee pain C KL grade  1 in one or both knees, KL grade  2 in one or both knees,
WOMAC function score
OA 0.755/0.637
Conf.Int.
0.680-0.830
C Maximal isometric quadriceps strength CI
C Mode 11 (Active Shape Modelling) IM
C Difﬁculties when jumping PQ
C Frequency biscuits (raisins)/week FQ
Lateral JSN C Fat percentage CI 0.731/0.549
Conf.Int.
0.654-0.808
C Mode 1, Mode 10, Mode 11 (Active Shape Modelling) IM
C Frequency of fruits/week FQ
C Concentration of Coll2-1NO2 adj. for creatinine BM
Medial JSN C Quality of life, Nr. years since menopause, Waist circumference CI 0.737/0.539
Conf.Int.
0.659-0.814
C Mode 15 (Active Shape Modelling) IM
C Freq. bananas/week FQ
C C1M concentration BM
KL incidence C BMI, HbA1c concentration CI 0.823/0.699
Conf.Int.
0.753-0.893
C Presence of OA on MRI IM
C Grinding/clicking sound when moving the knee PQ
C Frequency of apples and pears/week FQ
Variables are baseline measures divided according to the type of information provided: OA information (OA), clinical information (CI), Imaging-based information (IM), pain
questionnaire (PQ) and food questionnaire (FQ). The AUC column includes the AUC-CV, the AUC-Full and the 95% Conﬁdence Interval (Conf.Int.) of the AUC-Full.
N. Lazzarini et al. / Osteoarthritis and Cartilage 25 (2017) 2014e2021 2017using only ﬁve variables (smallest model). The second best per-
forming model is associated with the ACR criteria and provided an
AUC-Full of 0.788, however, it also contains the largest number of
variables (8 in total). Finally, the JSN outcome measures led to the
two lowest performance, respectively 0.731 for the lateral and
0.737 for the medial compartments. It is important to highlight
how the rank of the models, created with different outcome mea-
sures, does not change while considering AUC-Full or AUC-CV.
Table II shows that all the models incorporate variables of
diverse categories, each one is deﬁned by at least four different
categories of variables. The imaging-based variables are important
for the ACR criteria model as well for JSN lateral. In particular the
Active Shape Models, statistical shape models constructed after
placing 75 landmark points along the contours of the tibia, ﬁbula,
femur and medial femoral condyle on each radiograph and using
Principal Component Analysis to create independent modes of
shape variation. More details are provided in19,20. OA information
play a relevant role in the prediction of knee OA development when
considering the chronic pain as outcome measure. Food informa-
tion appears in almost every model (ACR criteria is the exception),
most variables are related to the fruit intake per week, while the
number of biscuits (sugar) consumed per week is used by the Knee
pain model. Finally, we notice the presence of BM already associ-
ated, from the literature, with the incidence of knee OA such as the
concentration of C1M, C2M14 and COLL2-1NO25.
All the performancewere found statistically signiﬁcant with a p-
value < 0.0001. None of the models, when trained with randomised
data, obtained higher AUC than what can be obtained from the
original versions of the data (reported in Table II).Model interpretation
The models generated from different knee OA outcome mea-
sures were interpreted in terms of both additive value and direction
of their components (variables).The additive value of each variable, within the predictive
models, was assessed performing a decremental analysis. In Fig. 3
we show the results of the analysis when using the Knee pain and
KL incidence models (the only two models comparable with the
literature ﬁndings). The full set of results, model by model, is
available in Section 1 of the Supplementary Material. The y-axis of
Fig. 3 represents the AUC values of each submodel, while the var-
iables deﬁning the submodels are represented over each bar. The
least important variables are highlighted in white, that is the var-
iables that are not present in the following submodels. The KL
scores (whether at baseline is  1 or  2) are the most valuable
information in the Knee pain model, by themselves, the two vari-
ables get a good AUC of 0.663. From the KL incidence measure
models we see that the two largest decreases in performance are
associated with the removal of the fruit intake per week and the
knee grinding/clicking information. As for the Knee pain, the one
variable model (presence of OA on MRI at baseline) can lead to an
interesting AUC of 0.617.
With the variable direction analysis, we determine if the change
in intensity (value) of a variable corresponds to an increase of the
probability to be affected by knee OA. That is, if a biomarker has a
positive or a negative association with the OA outcome measure.
Figure 4 shows the direction of two variables for the Knee pain and
KL incidence models. Each data point corresponds to the average
probability to belong to the positive (incidence) class. For binary
variables (e.g., KL grade  2) we report the distribution of the
probabilities of the two possible values. As expected, a baseline KL
gradetwo increases the probability for the knee OA incidence. We
also see that difﬁculties when jumping (high pain) might indicate
higher chance develop the condition. Conversely, at the bottom
plots of Fig. 4, is illustrated a negative association between the
frequency of apples and pears eaten per week and the knee OA
outcome measure. Finally, we observe how the analysis of MRI (at
baseline) might provide insights about the development of knee OA
in the individuals (overweight women in this instance) given its
positive association.
Fig. 2. ROC curves of the presented modes. The ROC curves generated by the best performing models using ﬁve knee OA outcome measures. The AUC values refer to the AUC-Full.
Fig. 3. Decremental models analysis. The decremental models generated using the Knee pain (left plot) and the KL incidence (right plot) measure for the knee OA deﬁnition. The
variable highlighted in white represents the least important one, not present in the subsequent decremental model.
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In this work, we developed ﬁve models that can be used to
predict the incidence of knee OA in overweight and obese women.
Different than the traditional approaches, mostly based on the
combination of univariate (where one variable at the time is
analysed) and multivariate (where multiple variables are analysed
together) logistic regression, we employed multivariate machine
learning techniques. We showed that using a small subset of the
available information (each model is deﬁned by at most eight
variables) is possible to accurately predict the incidence of knee
OA.
We searched the specialised literature to identify models that
can be compared with the predictive models generated using our
machine learning approach. In Tables III and IV we report a sum-
mary of the literature ﬁndings. We searched for models generated
using data where the OA deﬁnitionwas similar to ours. Comparablemodels were found only for the Knee pain and KL incidence outcome
measures. For a fair comparison, we report, for each literature
study, only the AUC obtained using an internal validation (some
studies also used external data to assess the performance). If
multiple models (deﬁned by different subset of variables) were
available, we considered only the best performing. We want to
highlight that these studies used a population that is different to
the one associated with the PROOF study. Hence, the comparison of
AUC values is just approximate. Nevertheless, such a comparison
provides an idea if the presented models perform in line with the
state-of-the-art literature. All the models found in the literature
were generated with the same statistical approach: a univariate
analysis followed by a multivariate logistic regression method.
In21e23 the validation protocol, employed to calculate the AUC
values, is not described. Therefore, we assume, as common practice
for clinical studies, that the published AUCs are equivalent to our
AUC-Full values. In24 is mentioned that a “10-fold cross-validation
Fig. 4. Variable direction analysis. The top plots show the direction of the “KL grade  2” and “Difﬁculties when jumping” variables from the Knee pain model. The bottom plots
illustrate the associations between the incidence of knee OA, the “Presence of OA on MRI” and the “Frequency of apples and pears eaten per week” variables from the KL incidence
model.
Table III
Summary of the KL incidence models identiﬁed in the specialised literature
Reference AUC OA deﬁnition Attributes
21 0.790 KL grade < 2 B/L
and KL  2 at F.U.
Gender, age,
BMI, knee pain
and KL score at B/L
22 0.690 KL grade < 2 B/L
and KL  2 at F.U.
Gender, age, BMI,
occupational risks,
family osteoarthritis,
previous knee injury
23 0.740 KL grade < 2 B/L
and KL  2 at F.U.
(5 year)
Gender, age, BMI,
minimum JSW,
osteophyte
JSW: Joint Space Width, B/L: baseline, F.U.: follow-up.
Table IV
Summary of the Knee pain models identiﬁed in the specialised literature
Reference AUC OA deﬁnition Attributes
23 0.600 Painful knee
at B/L;
painful knee at
F.U (4 and 5 year)
Age, pain intensity, minimum JSW,
osteophyte
24 0.623 Chronic right
knee pain
Osteophytes (OARSI grades 0e3)
femur medial compartment,
Chondrocalcinosis (grades 0e1)
medial compartment (data taken 1
year before the pain development)
24 0.620 Chronic right
knee pain
Osteophytes (OARSI grades 0e3)
femur medial compartment,
Chondrocalcinosis (grades 0e1)
medial compartment, Osteophytes
(OARSI grades 0e3) femur lateral
compartment (data taken 2 years
before the pain development)
JSW: Joint Space Width, B/L: baseline, F.U.: follow-up.
N. Lazzarini et al. / Osteoarthritis and Cartilage 25 (2017) 2014e2021 2019strategy has been used as a feature selection strategy”, however, is
not speciﬁed if the reported AUCs are associated with such strategy.
Our internal validation indicated an AUC of 0.823 for the KL inci-
dence model and an AUC of 0.755 for the Knee pain.
Table III shows that our model for the prediction of KL incidence
obtains higher performance than the models available in the
literature while using the same or fewer variables. A superior
performance also emerged when comparing the Knee pain model
(see Table IV). However, differently than for the KL incidence, our
Knee pain model is always larger (7 attributes) and more hetero-
geneous (imaging-based information, food (FQ) and pain ques-
tionnaire (PQ) data, OA and clinical information).Within our modes, imaging-based variables contain valuable
information for the risk for knee OA incidence. Every model of
Table II includes a variable from the imaging category (IM). In
addition, such an importance is conﬁrmed by Fig. 4, where is
illustrated a positive association between the presence of OA on
MRI at baseline and the incidence of knee OA. Overall, these results
suggest a need in re-evaluating a proper use of imaging information
a http://www.d-board.eu/dboard/index.aspx.
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for future knee OA development. However, it needs to be stressed
that not all imaging-based variables included in the ﬁnal models
are easy to obtain in primary care; such as the outcomes of statis-
tical shape modelling (‘Mode x’ variables). This warrants further
attention. Furthermore, we hope that the relevant role of MRI
features for the prediction of knee OA incidence in our model might
direct the design of new studies that focus on early detection or
early treatment of knee OA among a high-risk group of overweight
and obese women.
The models generated with different knee OA outcome mea-
sures do not share many biomarkers. This is primarily due to
the lack of overlap between incident individuals across different OA
deﬁnitions. The Venn diagram included in Section 5 of the
Supplementary Material illustrates this. There is no common
agreement between all the measures for any single incident indi-
vidual. The largest similarity occurs between ACR criteria and knee
pain, the two measures that also generated the most analogous
predictive models (this occurs because the ACR criteria can only be
positive in presence of knee pain). However, this low overlap might
also be a signed that potentially different factors play a role in
different aspects of the disease (radiographic onset, clinical onset,
etc.), hence each panel of biomarkers exists of unique factors. A
more tailored analysis in future works will be necessary to thor-
oughly characterise the potential link between models.
The proposed biomarkers can be grouped into two predictive
categories: early signs (e.g., pain while jumping) as well as risk
factors (e.g., BMI or waist circumference). The analysis performed
for this manuscript used all the data collected by the PROOF study
without discarding or ﬁltering any of the available variables, this
was to avoid any loss of relevant information. However, in future,
we would like to apply the same approach by considering either
only the early signs or the risk factors. Such an approachwill give us
the opportunity to propose different models that can be applied
according to the information available for each possible individual
been tested for the prediction of knee OA.
Several variables based on “wet” biomarkers of extracellular
matrix tissue turnover also provided information on the risk of
knee OA incidence. Both ACR criteria, medial and lateral JSN based
prediction models all contained blood or urine-based biomarkers.
C1M and C2M seemed to be negatively associated with the inci-
dence OA deﬁned by ACR criteria and medial JSN, in a similar way,
COLL2-1NO2 showed a negative relationship with incidence OA
deﬁned by lateral JSN. Previous studies have found correlations
between OA severity and C1M14 and a difference in C2M levels
between OA and healthy subjects25. Furthermore, the negative as-
sociation between COLL2-1NO2 and OA incidence is in line with a
previous study also performed using the PROOF cohort5 with a
different analytical approach (binary logistic regression), thus
providing some degree of conﬁrmation of both the relevance of the
biochemical marker and the goodness of our methodology. These
ﬁndings suggest that assessment of structural degradation products
from the extracellular matrix in body ﬂuids may provide valuable
information on the development OA and prediction of disease
incidence in high-risk groups.
The presented models perform quite well in the discrimination
of incidence and non-incidence knee OA among overweight and
obese women. Their performance can be considered as “fair” (AUCs
is between 0.70 and 0.80) and “good” (AUCs between 0.80 and
0.90). However, it will be necessary to evaluate the predictive po-
wer of each model using an independent set of individuals
(external validation). Given that it will be extremely unlikely to
obtain new validation data that will include all the variables
employed by our models, the role of the decremental analysis will
be fundamental. Based on the variables available in the new data,the performance of the best ﬁtting submodel will be easily
extracted from the decremental analysis, illustrated as in Fig. 3, and
compared with the AUCs obtained from the new external samples.
Contributions
Conception and design of the study (NL, JB, JR). Performed the ex-
periments (NL, JB). Analysis and interpretation of the data (NL, JB,
JR, AB, CS, SZ, YH). Drafting of the article and ﬁnal approved of the
submitted version (NL, JB, JR, AB, CS, SZ, YH).
Conﬂict of interest
Yves Henrotin is CEO, President and Founder of Artialis SA (Spin-off
company of the University of Liege, Belgium). Anne-Christine Bay-
Jensen owns stocks in Nordic Bioscience.
Role of the funding source
This work was supported by the European Commission through the
D-BOARDa Consortium funded by European Commission Frame-
work seven programme (EU FP7; HEALTH.2012.2.4.5e2, grant
305815, Novel Diagnostics and Biomarkers for Early Identiﬁcation
of Chronic Inﬂammatory Joint Diseases) and by the UK Engineering
and Physical Sciences Research Council [grants EP/M020576/1, EP/
N031962/1].
This work was partly supported by a program grant of the Dutch
Arthritis Foundation for their centre of excellence “Osteoarthritis in
primary care” (grant LLT_19).
None of the study sponsor was involved with the design of the
study, analysis and interpretation of data nor in the writing of the
manuscript.
Acknowledgement
This work made use of the facilities of N8 HPC Centre of Excel-
lence, provided and funded by the N8 consortium and EPSRC [EP/
K000225/1]. The Centre is co-ordinated by the Universities of Leeds
and Manchester. We acknowledge the HPC facility at the School of
Computing of Newcastle University for providing the necessary
framework for the experiments.
Supplementary data
Supplementary data related to this article can be found at
https://doi.org/10.1016/j.joca.2017.09.001.
References
1. Wright RW, Boyce RH, Michener T, Shyr Y, McCarty EC,
Spindler KP. Radiographs are not useful in detecting arthro-
scopically conﬁrmed mild chondral damage [Internet]. Clin
Orthop Relat Res 2006;(442):245e51. Available from: http://
www.scopus.com/inward/record.url?eid¼2-s2.0-3364507
9681&partnerID¼40&md5¼ef956150bde0e5c31364b
945ccb73daf.
2. Mobasheri A, Henrotin Y. Biomarkers of (osteo)arthritis
[Internet]. Biomarkers 2015;20(8):513e8. Available from:
http://www.tandfonline.com/doi/full/10.3109/1354750X.
2016.1140930.
3. Kluzek S, Bay-Jensen A-C, Judge A, Karsdal MA, Shorthose M,
Spector T, et al. Serum cartilage oligomeric matrix protein and
development of radiographic and painful knee osteoarthritis. A
community-based cohort of middle-aged women [Internet].
Biomarkers 2015;20(8):557e64. Available from: http://www.
N. Lazzarini et al. / Osteoarthritis and Cartilage 25 (2017) 2014e2021 2021pubmedcentral.nih.gov/articlerender.fcgi?artid¼4819573
&tool¼pmcentrez&rendertype¼abstract.
4. Runhaar J, Sanchez C, Taralla S, Henrotin Y, Bierma-
Zeinstra SMA. Fibulin-3 fragments are prognostic biomarkers
of osteoarthritis incidence in overweight and obese women.
Osteoarthr Cartil 2016;24(4):672e8.
5. COLL2-1NO2 L ML, R J, H YE, VM M, O EH, V D, et al.
A biomarker for early knee osteoarthritis? [Internet]. Osteo-
arthr Cartil 2014;22(2014):S77. Available from: http://ovidsp.
ovid.com/ovidweb.cgi?T¼JS&PAGE¼reference&D¼emed12&
NEWS¼N&AN¼71463888.
6. Kluzek S, Arden NK, Newton J. Adipokines as potential prog-
nostic biomarkers in patients with acute knee injury [Internet].
Biomarkers 2015;20(8):519e25. Available from: http://www.
ncbi.nlm.nih.gov/pubmed/26006054%5Cnhttp://www.
pubmedcentral.nih.gov/articlerender.fcgi?artid¼PMC4819580.
7. AhmedU, Anwar A, Savage RS, CostaML,Mackay N, Filer A, et al.
Biomarkers of early stage osteoarthritis, rheumatoid arthritis
and musculoskeletal health [Internet]. Sci Rep 2015;5:9259.
Available from: http://www.nature.com/articles/srep09259%
5Cnhttp://www.nature.com/doiﬁnder/10.1038/srep09259.
8. Ashinsky BG, Coletta CE, Bouhrara M, Lukas VA, Boyle JM,
Reiter DA, et al. Machine learning classiﬁcation of OARSI-
scored human articular cartilage using magnetic resonance
imaging [Internet]. Osteoarthr Cartil 2015;23(10):1704e12.
Available from: http://www.sciencedirect.com/science/article/
pii/S1063458415011851.
9. Heard BJ, Rosvold JM, Fritzler MJ, El-Gabalawy H, Wiley JP,
Krawetz RJ. A computational method to differentiate normal
individuals, osteoarthritis and rheumatoid arthritis patients
using serum biomarkers [Internet]. J R Soc Interfac
2014;11(97):20140428. Available from: http://www.ncbi.nlm.
nih.gov/pubmed/24920114%5Cnhttp://www.pubmedcentral.
nih.gov/articlerender.fcgi?artid¼PMC4208376.
10. Lazzarini N, Bacardit J. RGIFE: a ranked guided iterative feature
elimination heuristic for the identiﬁcation of biomarkers
[Internet]. BMC Bioinf 2017;18(1):322. Available from: http://
www.ncbi.nlm.nih.gov/pubmed/28666416%5Cnhttp://
bmcbioinformatics.biomedcentral.com/articles/10.1186/
s12859-017-1729-2.
11. Runhaar J, VanMiddelkoopM, ReijmanM,Willemsen S, Oei EH,
Vroegindeweij D, et al. Prevention of knee osteoarthritis in
overweight females: theﬁrst preventive randomized controlled
trial in osteoarthritis. Am J Med 2015;128(8):888e95.
12. Hunter DJ, Guermazi A, Lo GH, Grainger AJ, Conaghan PG,
Boudreau RM, et al. Evolution of semi-quantitative whole joint
assessment of knee OA: MOAKS (MRI Osteoarthritis Knee
Score). Osteoarthr Cartil 2011;19(8):990e1002.
13. Hunter DJ, Arden N, Conaghan PG, Eckstein F, Gold G,
Grainger A, et al. Deﬁnition of osteoarthritis on MRI: results of
a delphi exercise. Osteoarthr Cartil 2011;19(8):963e9.14. Siebuhr AS, Petersen KK, Arendt-Nielsen L, Egsgaard LL,
Eskehave T, Christiansen C, et al. Identiﬁcation and charac-
terisation of osteoarthritis patients with inﬂammation derived
tissue turnover. Osteoarthr Cartil 2014;22(1):44e50.
15. Breiman L. Random forests. Mach Learn 2001;45(1):5e32.
16. Napierała K, Stefanowski J, Wilk S. Learning from imbalanced
data in presence of noisy and borderline examples. In:
Szczuka M, Kryszkiewicz M, Ramanna S, Jensen R, Hu Q, Eds.
Rough Sets and Current Trends in Computing: 7th Interna-
tional Conference, RSCTC 2010, Warsaw, Poland, June 28-30,
2010 Proceedings. Berlin, Heidelberg: Springer Berlin Heidel-
berg; 2010:158e67.
17. Alcala-Fdez J, Sanchez L, García S, del Jesus MJ, Ventura S,
Garrell JM, et al. KEEL: a software tool to assess evolutionary
algorithms for data mining problems. Soft Comput 2009;13(3):
307e18.
18. Hastie T, Tibshirani R, Friedman J. The elements of statistical
learning. Elements 2009;1:337e87.
19. Eggerding V, van Kuijk KSR, van Meer BL, Bierma-Zeinstra SM
a, van Arkel ER a, Reijman M, et al. Knee shape might predict
clinical outcome after an anterior cruciate ligament rupture
[Internet]. Bone Jt J 2014;96(6):737e42. Available from:
http://www.bjj.boneandjoint.org.uk/content/96-B/6/737.
abstract.
20. Haverkamp DJ, Schiphof D, Bierma-Zeinstra SM, Weinans H,
Waarsing JH. Variation in joint shape of osteoarthritic knees.
Arthritis Rheum 2011;63(11):3401e7.
21. Kerkhof HJ, Bierma-Zeinstra SM, Arden NK, Metrustry S, Cas-
tano-Betancourt M, Hart DJ, et al. Prediction model for knee
osteoarthritis incidence, including clinical, genetic and
biochemical risk factors. Ann Rheum Dis 2014;73(12):
2116e21.
22. Zhang W, McWilliams DF, Ingham SL, Doherty S a, Muthuri S,
Muir KR, et al. Nottingham knee osteoarthritis risk prediction
models. Ann Rheum Dis 2011;70(9):1599e604.
23. Kinds MB, Marijnissen ACA, Vincken KL, Viergever MA, Dros-
saers-Bakker KW, Bijlsma JWJ, et al. Evaluation of separate
quantitative radiographic features adds to the prediction of
incident radiographic osteoarthritis in individuals with recent
onset of knee pain: 5-year follow-up in the {CHECK} cohort.
Osteoarthr Cartil 2012;20(6):548e56.
24. Galvan-Tejada JI, Celaya-Padilla JM, Trevi~no V, Tamez-Pe~na JG.
Multivariate radiological-based models for the prediction of
future knee pain: data from the {OAI}. Comput Math Methods
Med 2015:1e10. 2015.
25. Bay-Jensen AC, Liu Q, Byrjalsen I, Li Y, Wang J, Pedersen C, et al.
Enzyme-linked immunosorbent assay (ELISAs) for metal-
loproteinase derived type II collagen neoepitope, CIIM-
Increased serum CIIM in subjects with severe radiographic
osteoarthritis. Clin Biochem 2011;44(5e6):423e9.
